Here, we found that silencing of ANXA2 reduced cancer stem cell formation ability (Supplementary Figure 2A) and expression of CSC associated markers Oct4, Sox2 and Nanog (Supplementary Figure 2B). The gene discussed is ANXA2; the disease is cancer.